SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-20-006355
Filing Date
2020-06-23
Accepted
2020-06-22 21:50:18
Documents
14

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 510785
2 filename2.htm EX-10.21 43924
3 filename3.htm EX-10.53 154507
4 filename4.htm EX-10.54 591795
5 filename5.htm EX-10.55 153046
6 filename6.htm EX-10.56 251190
7 filename7.htm EX-10.57 51333
8 filename8.htm EX-10.58 462616
9 filename9.htm EX-10.59 32177
10 GRAPHIC g945110g0616114414535.jpg GRAPHIC 2602
11 GRAPHIC g945110g0620094538784.jpg GRAPHIC 5974
12 GRAPHIC g945110g34b40.jpg GRAPHIC 130729
13 GRAPHIC g945110g54j15.jpg GRAPHIC 28858
14 GRAPHIC g945110g91n68.jpg GRAPHIC 31103
  Complete submission text file 0000950123-20-006355.txt   2527694
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-03240 | Film No.: 20980179
SIC: 2836 Biological Products, (No Diagnostic Substances)